共 50 条
- [2] Tofacitinib in active ulcerative colitis: Analysis of efficacy based on patient-reported outcomes [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S51 - S51
- [4] Discrepancies between patient-reported outcomes, endoscopic, and histologic appearance in ulcerative colitis [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S61 - S61
- [6] Validity and Responsiveness of the Patient-reported Outcomes Measurement Information System in Children With Ulcerative Colitis [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 73 (01): : 67 - 72
- [7] Correlation Between Patient-Reported Outcomes (Pros) and Patient-Reported Disease Activity in Ulcerative Colitis (UC): Findings From the ICONIC Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S432 - S433
- [8] Correlation between patient-reported outcomes (PROs) and patient-reported disease activity in Ulcerative Colitis (UC): Findings from the ICONIC study [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S382 - S383
- [9] Patient-reported adherence rates to topical therapies in ulcerative colitis [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S419 - S419
- [10] Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes [J]. BMC GASTROENTEROLOGY, 2015, 15